Liothyronine

Basic liothyronine information

• INN (international nonproprietary name): Liothyronine (as liothyronine sodium)
• Brand names available in the United Kingdom: Liothyronine sodium tablets (generic)
• ATC code: H03AA02
• Forms and dosages: Tablets 5 mcg, 10 mcg, 20 mcg; injection for hospital use
• Manufacturers in the United Kingdom: Various generic manufacturers
• Registration status in the United Kingdom: MHRA-licensed; prescription-only medicine (POM)
• OTC / Rx classification: Prescription-only medicine (POM)

Legal status and availability in the UK

Liothyronine is a prescription-only medicine (POM) in the UK.

In our online pharmacy, liothyronine is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Availability and prescribing in the UK

Liothyronine tends to be stocked in smaller quantities and may be special-ordered.

NHS prescribing is usually restrictive and levothyroxine remains first-line, so liothyronine is often only issued after specialist review or under local shared-care agreements.

What liothyronine is (drug basics)

Mechanism, INN, legal status in the UK

What does liothyronine actually do?

Liothyronine, listed as liothyronine sodium (INN liothyronine), is the synthetic active thyroid hormone T3.

The drug acts on nuclear thyroid receptors to increase metabolic rate, raise thermogenesis and change gene transcription in target tissues.

In clinical practice it is reserved for situations where rapid onset or direct T3 activity is required because levothyroxine (T4) usually converts peripherally to T3.

Liothyronine is a prescription-only medicine (POM) in the United Kingdom and regulated by the MHRA.

Many available brands are specialist or limited-licence products and pack sizes tend to be small blisters with microgram tablets.

• INN: Liothyronine (liothyronine sodium)
• Salt form: Sodium salt of triiodothyronine (T3)
• Regulatory status: Prescription-only (POM), MHRA regulated

Indications and common clinical uses

Approved indications, specialist uses and off-label scenarios

When is liothyronine used clinically?

Primary approved use is for hypothyroidism when T3 therapy is specifically indicated or when rapid action is needed.

Examples include patients with reduced peripheral conversion of T4 to T3, or those after thyroidectomy who require tailored replacement.

In hospital practice intravenous liothyronine may be used in myxoedema coma as part of critical care protocols.

Short-term liothyronine is sometimes used to accelerate metabolic response under specialist supervision.

Off-label roles can include adjunctive treatment in selected, treatment-resistant depression cases or persistent symptoms despite normal thyroid function tests, but such use must be specialist-led and monitored.

• Approved indications: Specific cases of hypothyroidism needing T3
• Specialist inpatient uses: Myxoedema coma (IV liothyronine)
• Off-label examples: Adjunct for selected depression cases or persistent symptomatic patients — only with specialist oversight

Available preparations, strengths and packaging

Typical UK presentations and manufacturer notes

What preparations of liothyronine are commonly supplied?

Oral liothyronine tablets are supplied in microgram strengths — commonly 5 µg, 10 µg and 20 µg depending on manufacturer.

Injectable IV liothyronine is available for hospital use in emergencies such as myxoedema coma or when enteral absorption is not possible.

Packs are usually small blister cards because specialist prescribing and frequent monitoring reduce the need for large counts.

Storage is at room temperature, away from moisture and light, and packs should be kept in original packaging to avoid confusion with other microgram-strength tablets.

Supply notes

Because liothyronine is specialist-led, community pharmacies often hold minimal stock and will order to patient-specific prescriptions.

Dosing: initiation, titration and maintenance

Practical regimens and UK prescribing norms

How should dosing be started and adjusted?

Start low and titrate slowly, particularly in older patients or those with cardiac risk.

Typical adult initiation for symptomatic patients is 5–10 µg daily, with increments of 5–10 µg every one to three weeks guided by symptoms and thyroid function tests.

Maintenance doses frequently fall in the 25–75 µg/day range and are often split between morning and early afternoon because of liothyronine’s short half-life.

Young, otherwise well patients may require higher doses tailored individually, but avoid abrupt large increases due to cardiac risk.

• Starting doses: 5–10 µg daily for at-risk patients; higher for low-risk younger adults
• Titration schedule: Increase by 5–10 µg every 1–3 weeks while monitoring symptoms and TFTs
• Maintenance: Often 25–75 µg/day, commonly divided

Elderly patients and those with ischaemic heart disease require specialist oversight and slower titration with ECG monitoring where indicated.

Switching from levothyroxine — combination therapy (T4/T3)

How pharmacists support switching and rationale

Why might a clinician switch to combination T4/T3 therapy?

Some patients report persistent symptoms on levothyroxine despite normal blood tests, prompting a specialist trial of liothyronine alone or in combination with levothyroxine.

Combination approaches vary; clinicians may replace a small portion of levothyroxine with liothyronine to provide a physiological mix of T4 and T3.

A pragmatic approach is to introduce liothyronine 5–10 µg while reducing levothyroxine appropriately and rechecking TSH, free T4 and free T3 at around six to eight weeks.

Pharmacists should confirm specialist prescription, advise on split dosing, and counsel patients to report palpitations, chest pain or severe anxiety immediately.

Safety, contraindications and adverse effects

Key warnings

What safety issues should be front of mind?

Common dose-related adverse effects include palpitations, tremor, insomnia, anxiety, heat intolerance and weight loss.

Serious risks arise from excess thyroid hormone and include precipitation of angina, arrhythmias and accelerated osteoporosis with long-term oversupply.

Absolute contraindications include untreated adrenal insufficiency, thyrotoxicosis and recent acute myocardial infarction or unstable ischaemic heart disease.

Liothyronine should be used cautiously in elderly patients and those with known cardiac disease; specialist review and ECG monitoring may be necessary.

• Mild side effects: Tremor, nervousness, sweating, insomnia
• Serious risks: Arrhythmia, angina, long-term bone loss
• Red flags: Chest pain, severe palpitations, sudden shortness of breath — seek urgent care

Drug interactions and monitoring essentials

Clinically important interactions and TFT follow-up

Which interactions are clinically relevant for liothyronine?

Liothyronine potentiates oral anticoagulants such as warfarin, increasing bleeding risk and often reducing required anticoagulant dose; INR should be checked after initiation or dose changes.

The drug may change insulin and oral hypoglycaemic needs, so glucose control should be reviewed when thyroid dose changes.

Amiodarone and lithium impact thyroid physiology and may complicate dosing decisions; liaison with the prescriber is advised.

Calcium, iron supplements and bile acid sequestrants can reduce oral absorption; advise spacing these by about four hours from liothyronine doses.

• Key interacting classes: Anticoagulants, insulin/antidiabetics, amiodarone, lithium, calcium/iron supplements
• Monitoring timetable: Baseline TFTs, repeat 6–8 weeks after any dose change, then individualised checks
• Pharmacist actions: Flag INR checks, counsel on spacing supplements, confirm medication list for interactions

Counselling points for patients (how to take, side-effect recognition)

Clear, practical advice

What practical advice should patients receive at the counter?

Take liothyronine consistently at the same time each day, usually in the morning; if taken twice daily, the second dose should be mid-afternoon to avoid insomnia.

Space liothyronine from calcium and iron supplements by three to four hours to preserve absorption.

If a dose is missed, take it when remembered unless it is close to the next scheduled dose — do not double up.

Advise patients to watch for signs of excess thyroid such as palpitations, chest pain, marked anxiety or severe tremor and to seek urgent care for chest pain or severe arrhythmia.

Store medicine in its original packaging, away from moisture and heat, and return unused medicines to the pharmacy for safe disposal.

• Do: Take morning dose consistently, report palpitations or insomnia
• Don’t: Take late afternoon doses that may cause sleep problems or double missed doses
• When to call GP: New chest pain, severe breathlessness, fainting or sudden worsening symptoms

Laboratory monitoring and interpreting results

TSH, free T4, free T3 targets and practical timelines

How should clinicians and pharmacists interpret thyroid tests on liothyronine?

Liothyronine increases circulating T3 quickly and may suppress TSH even when peripheral T4 appears normal, so interpretation must be clinical as well as biochemical.

Baseline tests should include TSH, free T4 and free T3 prior to a dose change, and repeat testing at about six to eight weeks after any adjustment.

Because T3 equilibrates faster than T4, symptoms may change earlier than lab values; however allow the standard interval for meaningful TFT changes before major dose decisions.

Avoid aiming for sustained TSH suppression in most patients because that raises risk of atrial fibrillation and osteoporosis, particularly in older adults.

Use in pregnancy, breastfeeding and fertility

Risks, guidance and prescribing notes

Is liothyronine safe in pregnancy?

Pregnancy requires effective thyroid replacement because maternal hypothyroidism affects foetal development, and levothyroxine is generally preferred due to steady levels and extensive data.

Liothyronine crosses the placenta and is reserved for specialist use in pregnancy when levothyroxine is inadequate or rapid action is needed.

For breastfeeding, liothyronine appears in milk in small amounts and specialist review should balance maternal benefit and infant exposure.

In fertility care, adequate thyroid replacement supports conception and early pregnancy; clinicians adjust therapy preconception and monitor closely.

• Pregnancy checklist: Prefer levothyroxine; consider liothyronine only with specialist advice
• Breastfeeding: Specialist oversight recommended; monitor infant if use is necessary
• Fertility: Ensure euthyroid state before conception; frequent monitoring in early pregnancy

Special clinical scenarios (myxoedema coma, paediatrics, cardiac disease)

Emergency vs routine management and pharmacy role

What changes in emergency or specialised contexts?

Myxoedema coma is a medical emergency treated in hospital with intravenous liothyronine as part of critical care protocols; these preparations are hospital-only and ordered through hospital pharmacy.

Paediatric use of liothyronine is uncommon as first-line therapy and requires paediatric endocrinology input for dosing and monitoring.

In patients with cardiac disease, liothyronine can precipitate ischaemia or arrhythmia and cardiology input is recommended before initiation or escalation.

Pharmacists should confirm the stated indication and ensure specialist oversight for these scenarios and contact the prescriber if uncertainty exists.

• Emergency dosing (high-level): IV liothyronine under critical care — hospital supply only
• Paediatric considerations: Specialist paediatric endocrinologist involvement essential
• Cardiac disease: Cardiology review recommended before starting or increasing dose

Storage, disposal, missed dose and overdose management

Practical pharmacy notes and patient leaflets

How should liothyronine be stored and what to do in overdose?

Store at room temperature, away from light and moisture, and keep tablets in their original blister to avoid confusion between microgram strengths.

Return unused packs to the pharmacy for safe disposal; do not flush medications down the toilet.

If a dose is missed, the patient should take it when remembered unless it is near the next dose — do not double the next dose.

Overdose symptoms include palpitations, chest pain, severe tremor, marked anxiety and fever and require urgent medical attention.

• Storage checklist: Room temperature, original pack, away from children and pets
• Emergency actions for overdose: Call emergency services for chest pain or severe symptoms
• Patient leaflet items: Dosing times, spacing supplements, red-flag symptoms, disposal instructions

Delivery across the United Kingdom